SCHEMBL4617002

SCHEMBL4617002

CCc1ccc(S(=O)(=O)c2ccc(F)cc2)cc1S(=O)(=O)Cl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 3/20 0.42
HSD11B1 P28845 2/20 0.42
ALDH1A1 P00352 1/20 0.41
HTR2A P28223 3/20 0.40
HTR2C P28335 2/20 0.40
HTR2B P41595 1/20 0.40
CYP2D6 P10635 1/20 0.40
METAP2 P50579 3/20 0.39
KCNH2 Q12809 2/20 0.37
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP3 P08254 1/20 0.37
MMP9 P14780 1/20 0.37
MMP12 P39900 1/20 0.37
MMP13 P45452 1/20 0.37
MMP14 P50281 1/20 0.37
ABCC9 O60706 1/20 0.37
ABCC8 Q09428 1/20 0.37
KCNJ11 Q14654 1/20 0.37
KCNJ8 Q15842 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4615836 0.90 HTR2A (0.41) SFRP1HSD11B1ALDH1A1HTR2AHTR2C
SCHEMBL4618745 0.86 SFRP1 (0.55) SFRP1HSD11B1ALDH1A1HTR2AHTR2C
SCHEMBL29054624 0.83 KDM4E (0.41) CYP2D6METAP2
SCHEMBL11046300 0.81 ALDH1A1 (0.37) SFRP1HSD11B1ALDH1A1CA2
SCHEMBL4616004 0.81 LMNA (0.45) SFRP1HSD11B1ALDH1A1HTR2CHTR2B
SCHEMBL4616844 0.77 HTR2C (0.43) HSD11B1ALDH1A1HTR2AHTR2CHTR2B
SCHEMBL4618007 0.76 SFRP1 (0.46) SFRP1HSD11B1ALDH1A1HTR2AHTR2C
SCHEMBL4616832 0.75 HSD11B1 (0.45) SFRP1HSD11B1ALDH1A1HTR2AHTR2C
SCHEMBL27713276 0.75 SMN1; SMN2 (0.51) HSD11B1ALDH1A1HTR2AHTR2CMETAP2
SCHEMBL4616039 0.75 CA2 (0.41) HSD11B1ALDH1A1HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101208299-A Diarylsulfone sulfonamides and use therof WYETH CORP (US) 2008-06-25 CN disclosed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885HSD11B1 205/4885ALDH1A1 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.